H35.3
Conditions
Interventions
Group 1: Patients with untreated geographic atrophy secondary to advanced AMD are followed over a median of 5 years using 6-month non-interventional controls. Parameters are determined such as best co
Sponsors
Augenklinik SulzbachKnappschaftsklinikum Saar/Sulzbach
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis: untreated geographic atrophy secondary to advanced AMD - reliable assessment of the fundus (sufficiently clear refractive media)
Exclusion criteria
Exclusion criteria: serious systemic diseases that hinder clinical examinations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to observe the natural progress of geographic atrophy secondary to advanced dry AMD in the largest possible cohort of patients. Our focus here is on observing the progression of the disease over months and years. On the basis of this data, therapy recommendations can be worked out in the future or risk factors can be reduced in a specific manner. | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression of the disease - patients with various underlying diseases and ophthalmological secondary diagnoses are included in order to work out possible correlations of various influencing factors | — |
Countries
Germany
Contacts
Public ContactNadja Khatami-Kalki
Augenklinik SulzbachKnappschaftsklinikum Saar/Sulzbach
Outcome results
None listed